Your institution may have access to this item. Find your institution then sign in to continue.
Title
Efavirenz tablets.
Abstract
The article reports on several chemical tests which the World Health Organization conducted in 2010 on the antiretroviral reverse transcriptase inhibitor drug Efavirenz to determine the drug's safety and efficacy. A discussion of recommendations which the organization offered for the proper strength and storage of the drug is presented.